We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+0.98%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
AUM
$1.59B
AUM Growth
-$264M
Cap. Flow
-$115M
Cap. Flow %
-7.24%
Top 10 Hldgs %
70.24%
Holding
130
New
38
Increased
16
Reduced
8
Closed
51

Sector Composition

Rank Sector Weight
1 Healthcare 9.68%
2 Industrials 7.06%
3 Financials 4.52%
4 Technology 3.87%
5 Utilities 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALV
76
DELISTED
KalVista Pharmaceuticals
KALV
-50,000
Closed -$891K
LBTYK icon
77
Liberty Global Class C
LBTYK
$3.5B
-174,462
Closed -$3.8M
NBR icon
78
CALL
Nabors Industries
NBR
$1.17B
-200
Closed -$29K
ON icon
79
ON Semiconductor
ON
$30.7B
-79,800
Closed -$1.95M
PACB icon
80
Pacific Biosciences
PACB
$435M
-600,000
Closed -$3.08M
SPR
81
PUT
DELISTED
Spirit AeroSystems
SPR
-498,400
Closed -$36.3M
TDOC icon
82
Teladoc Health
TDOC
$1.66B
-38,800
Closed -$3.25M
UA icon
83
Under Armour Class C
UA
$2.95B
-119,607
Closed -$2.29M
W icon
84
PUT
Wayfair
W
$11.8B
-42,000
Closed -$3.8M
WVE icon
85
CALL
Wave Life Sciences
WVE
$1.12B
-50,000
Closed -$401K
X
86
PUT
DELISTED
US Steel
X
-195,000
Closed -$2.23M
XBI icon
87
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
-100,000
Closed -$9.52M
CPE
88
CALL
DELISTED
Callon Petroleum Company
CPE
-10,000
Closed -$483K
ICPT
89
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-16,000
Closed -$1.98M
ENTXW
90
CALL
DELISTED
Entera Bio Ltd. Warrant
ENTXW
-337,673
Closed -$64K
APTO
91
DELISTED
Aptose Biosciences, Inc.
APTO
-446
Closed -$1.14M
SIOX
92
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-598,700
Closed -$3.07M
OYST
93
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-21,147
Closed -$517K
DRNA
94
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-40,000
Closed -$881K
KDMN
95
DELISTED
Kadmon Holdings, Inc.
KDMN
-280,000
Closed -$1.27M
IMMU
96
DELISTED
Immunomedics Inc
IMMU
-47,500
Closed -$1M
IMMU
97
PUT
DELISTED
Immunomedics Inc
IMMU
-47,500
Closed -$1M
PGNX
98
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-100,000
Closed -$509K
RARX
99
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-50,000
Closed -$2.35M
AVX
100
DELISTED
AVX Corporation
AVX
-100,000
Closed -$2.05M

Similar funds

DLD Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, DLD Asset Management held 130 positions worth $1.59B, down 14% from $1.85B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

DLD Asset Management withdrew a net $115M in Q1 2020, closing 51 positions and reducing 8 holdings. Its most notable exit was Zayo Group Holdings, Inc., an estimated $22.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 5.9% a quarter earlier, followed by Industrials and Financials.

Against the trend, DLD Asset Management opened a new position in E*Trade Financial Corporation worth $26.6M.

  • DLD Asset Management's largest Q1 2020 buy was E*Trade Financial Corporation: 774,749 shares worth $26.6M.
  • DLD Asset Management added most to El Paso Electric Company in Q1 2020, an estimated $45.1M increase.
  • DLD Asset Management's biggest Q1 2020 reduction was Tiffany & Co., cutting an estimated $18.6M.
  • DLD Asset Management fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $22.5M.
  • DLD Asset Management's ten largest holdings make up 70% of its $1.59B portfolio in Q1 2020.
  • DLD Asset Management opened 38 new positions and closed 51 in Q1 2020.
  • DLD Asset Management's portfolio value fell 14% quarter-over-quarter to $1.59B.

Based on DLD Asset Management's 13F filing for Q1 2020, filed 14 May 2020.